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Introduction 26
Fast and accurate variant calling is essential for both research and clinical applications of 27 human genome sequencing 1,2 . Algorithms, best practices and benchmarking guidelines have 28 been established for how to use Illumina sequencing to call germline small variants, 29 including single-nucleotide polymorphisms (SNPs) and insertions/deletions (indels) 3-6 . In 30 recent years, single-molecule sequencing (SMS) technologies have emerged for a variety of 31 important applications 7 . These technologies, which are also known as the third-generation 32 sequencing technologies, generate sequencing reads two to three orders of magnitude 33 longer than Illumina reads (10-100kbp versus 100-250bp). The long read length has made 34 the new SMS technologies, including Pacific Biosciences (PacBio) and Oxford Nanopore 35 Technology (ONT), unprecedentedly powerful for resolving complex genome assembly 36 problems and for detecting large structural variants 8 . However, currently available SMS 37 technologies also have a significantly higher base error rate of 3-15% 9 , making the variant 38 calling methods previously designed for Illumina sequencing inapplicable to SMS 39 technologies. The lack of accurate tools for efficient variant calling has limited SMS 40 technologies from being applied to the many problems that require SNPs and small indels. 41
42
In our previous work, we developed Clairvoyante 10 , a germline small variant caller for single 43 molecule sequencing data. Clairvoyante does not require sequence assembly and calls 44 variants directly from read alignments. Clairvoyante adopts a deep convolutional neural 45 network, so that by using the truth variants called and orthogonally verified in seven human 46 individuals by the Genome In A Bottle (GIAB) consortium [11] [12] [13] , Clairvoyante can be trained 47 for variant calling on any new type of sequencing data without the need to look into its 48 error profile and build a hand-crafted model. Clairvoyante takes pileup data as input and 49 runs quickly. However, Clairvoyante's design is unable to call multiallelic variants or indels 50 longer than four bases. These defects remain to be solved. Meanwhile, the limit of using 51 pileup data and deep neural networks for variant calling remains to be explored. 52
53
In this study, we present Clair, a fast and accurate system for germline small variant calling 54 using single molecule sequencing data. With an entirely different network architecture and 55 learning tasks (i.e. output components), Clair resolves the multiallelic and long indel variant 56 calling problems that have prevented Clairvoyante from calling all types of small variants. 57
We describe in detail the methods we tried that either worked or did not work for 58
improving Clair's performance. For ONT datasets 14 although Clair was seven times faster. Looking into the false positive (FP) and false negative 64 (FN) variants of the three sequencing technologies showed that except for variants with 65 insufficient coverage by chance, most of the others could be resolved using complete read 66 alignments instead of pileup data or else could not be resolved at all, even with a manual 67 inspection. 68
Results

69
Overview of Clair
70
Clair is a four-task, five-layer recurrent neural network with two bi-directional LSTM layers 71 followed by three feedforward layers (Figure 1) . Clair takes a BAM file as input to find 72 candidate variants with any minor allele frequencies larger than a threshold (typically 73 between 0.1 and 0.2), and then computes a pileup of the candidates and converts the 74 summaries into a tensor. In a tensor, the allelic counts of bases and gaps on both strands of 75 a candidate variant and its 16 flanking bases are encoded into 1,056 integer values. More 76 details and pseudo code are available in the Methods section. As discussed in the 77 Clairvoyante paper, one major unsolved problem was how to support the calling of multi-78 allelic variants (i.e., variants with two alternative alleles). In Clair, the problem is solved by 79 using four new (deep learning) tasks that are entirely different from Clairvoyante. These are: 80 1) a 21-genotype probabilistic model with 21 probability outputs; 2) the use of three 81 probabilities for the input, including a homozygous reference (0/0 genotype), a 82 heterozygous variant (0/1) or a homozygous variant (1/1); 3) the length of the first indel 83 allele, with 33 probabilities representing a length of '<-15bp', '-15bp', '-14bp', …, '-1bp', 84 '0bp', '1bp', …, '15bp', '>15bp'; and 4) the length of the second indel allele. The 21-genotype 85 probabilistic model can represent all possible genotypes of a diploid sample at the genome 86 position. The length of indels longer than 15bp cannot be directly inferred from the third 87 and fourth tasks, so Clair includes an additional step that re-scans the alignments. More 88 details on each of these steps can be found in the Methods section. The four tasks make 89 their own decisions and are designed to cross-validate each other. For example, task two is 90 a coarse-grained version of task one and can veto the decision made by task one. in multiple experiments with ONT data. Supplementary Table 1 predecessor Clairvoyante on both SNP and indel calling (overall F1-score 97.40% versus 141 93.45%). Clair had a slightly higher F1-score on SNPs than Longshot (98.53% versus 98.41%), 142
but Longshot detects only SNPs, and Clair ran five times faster than Longshot (320 versus 143 1,797 minutes). Clair had a better performance than Medaka (overall F1-score 97.40% 144 versus 94.81%) and ran 30 times faster (320 versus 10,817 minutes). It is worth mentioning 145 that we didn't benchmark Nanopolish 19 , which is also capable of variant calling on ONT data, 146 because it also requires raw signals as input, which are not publicly available for HG002. 147
148
We ran further experiments to answer five additional questions about Clair, as follows. 149
150 Is the Clair model reference-genome specific? In our experiments, performance did not 151 depend on whether we used GRCh37 or GRCh38. The performance of 1:168x|2:64x and 152 1:168x|2:64x(b37) was similar; the latter experiment tested HG002 GRCh37 read alignments 153 on a model trained using HG001 GRCh38 read alignments. Actually, 1:168x|2:64x(b37) 154 performed slightly better than 1:168x|2:64x, with a 0.18% better F1-score on SNPs, and 155 1.4% on indels. 156 157 Does higher coverage in the test sample helps improve variant calling performance? Yes, 158 but improvement seems to asymptote at ~60-fold coverage. In a comparison of 159 1:168x|2:64x to 1:168x|2:32x, the overall F1-score increased from 94.10% to 97.40% 160 (+3.30%), the SNP from 95.51% to 98.53% (+3.02%), and the indel from 68.87% to 77.34% 161 (+8.47%). Further increasing the coverage in the test sample will note significantly increase 162 the variant calling performance as we discuss below. 163 164 Does higher coverage for model training help improve variant calling performance? Yes, 165 but it depends on the coverage of the test sample. In a comparison of 1:124x|2:64x to 166 1:44x|2:64x, the overall F1-score increased from 96.84% to 97.51% (+0.67%), the SNP from 167 98.01% to 98.54% (+0.53%), and the indel from 75.78% to 78.44% (+2.66%). In a comparison 168 of 1:168x|2:64x to 1:124x|2:64x, the performance was similar, or even slightly dropped 169 from 97.51% to 97.40% overall. One possible reason is that the lower coverage test sample 170 cannot benefit from the much higher coverage used for model training. We propose how to 171 deal with excessively high coverage in test samples (i.e., coverage exceeding that used in 172 
What is the upper bound on performance? 183
To determine Clair's performance cap using the current ONT data, we intentionally 184 overfitted Clair by adding the samples we are going to test to the model training. Even 185 though Clair is designed with multiple generalization techniques, including 'dropout' and 'L2 186 regularization', exposing the test samples to model training is a biased evaluation, and if a 187 true variant is not called even after this biased training, this suggests the input signal is 188 simply too weak. The two tests we did were 1:168x+2:64x|2:64x and 1:168x+2:64x|1:168x. 189
Although the test sample coverage in the first test was much lower than that in the second 190 (64-fold against 168-fold), their performance was similar, with the overall F1-score at 191 97.77% and 97.82%, SNP at 98.75% and 98.77%, and indel at 79.92% and 81.37%. The 192 biased test 1:168x+2:64x|2:64x did not significantly outperform 1:168x|2:64x; the overall 193 F1-score increased from 97.40% to 97.77% (+0.33%), SNP from 98.53% to 98.75% (+0.22%), 194 and indel from 77.34% to 79.92% (+2.58%). Even with this biased experiment, we observed 195 that the performance of using Clair on the current ONT data was capped at about 97.8% F1-196 score overall, 98.8% on SNPs, and 80% on indels. We consider how the new ONT chemistry Table 2 shows a detailed 203 analysis of each FP and FN. Within the 100 FPs, the three largest categories are "Incorrect 204 allele with AF≥0.2" (41/100), "Homopolymer" (25/100), and "Tandem repeat" (11/100). 205 "Incorrect allele with AF≥0.2" means that at the FP variant, an incorrect allele dominates 206 other alleles in the read alignments (including the correct one), and the incorrect allele has a 207 frequency ≥20%. "Homopolymer", "Tandem repeat", and "Low complexity region" mean 208 that the FP variant is in a repetitive region, which remains difficult for ONT base-calling. It is 209 worth mentioning that these repetitive regions are ≤10bp because we removed all GA4GH 210 low-complexity regions longer than 10bp from benchmarking. It may not be possible to 211 perfectly resolve these three categories for FP variants using pileup data for variant calling, 212 although complete read alignments might help to provide better precision. Three out of 100 213
FPs had "Incorrect insertion bases", while two out of 100 were categorized as "Overlapping 214
insertions", which means that the alleles of two consecutive insertions overlapped each 215 other in an input tensor; thus, the correct allele cannot be resolved for both insertions. 216
These two categories of errors can be resolved using the '--pysam_for_all_indel' option in 217
Clair, but this slows down Clair for ONT data by a factor of up to ten times. Other errors, 218
including "Incorrect indel length" and "Incorrect zygosity", are errors made by Clair's neural 219 network. In the 100 FNs, the three major categories are "Correct allele with AF<0.25" 220 (54/100), "Homopolymer" (18/100), and "Tandem repeat" (7/100). "Correct allele with 221 AF<0.25" means that at the location of the missed (FN) variant, the signal of the correct 222 allele is rather weak, with allele frequency lower than 25%. One FN categorized as "More 223 than two possible alternative alleles" is an error due to an alignment error in segmental 224 duplications, in which more than two alternative alleles seem correct. for SNPs, which was 0.02% higher than the primary result, but 0.07% lower than that of 284 DeepVariant, and 99.57% for indels, which was 0.09% higher than the primary result, but 285 0.33% lower than that of DeepVariant. Similar to the ONT and PacBio CCS experiments, we 286 expect to fill in the performance gap through partially making use of complete read 287 alignments, as discussed in the Discussion section. 288
Discussion
289
In this paper we present Clair, a germline small variant caller for single molecule sequencing 290 data. The name Clair means 'clear' in French, echoing its predecessor, named Clairvoyante, 291 meaning 'clear seeing'. Clair adds new methods to solve problems that Clairvoyante had 292 trouble with, including multiallelic variant calling and long indel calling. In our experiments 293 on ONT data, Clair outperformed all existing tools in terms of precision, recall and speed. On 294 PacBio CCS and Illumina data, Clair performed slightly worse than DeepVariant, but ran 295 about an order of magnitude faster. Looking closer at the FP and FN variants shows that 296
Clair is approaching the limit on how accurately it can call variants using pileup data. Some 297 of the erroneous variant calls can be corrected using complete read alignments instead of 298 pileup data. However, dealing with complete read alignments requires a more powerful 299 neural network design with much greater computational demands. In the future, we will 300 explore using an ensemble method to handle the majority of the variants using Clair, while 301 for the extremely tricky ones we will use a new, more sophisticated method. 302
303
The quality and sufficiency of training data is key to the performance of Clair, as well as 304 other deep learning based variant callers, such as DeepVariant. To train a model for 305 production purposes, we used five samples (HG001 to 5) for Illumina data, but only two 306 samples (HG001 and HG002) for ONT, due to the limited availability of public high-coverage 307 whole genome sequencing datasets for the GIAB samples. ONT sequencing of the other 308 GIAB samples is ongoing, and more data will be available in the near future. With additional 309 datasets, we expect to see even higher performance in Clair on ONT data. 310 311 On ONT data, although Clair performed the best, its indel calling precision and recall were 312 only about 80%, even excluding GA4GH low-complexity regions, which leaves substantial 313 room for improvement. While the precision can be further improved by considering 314 complete read alignments, the recall is bounded by input and can be improved only with a 315 lower read-level base-calling error rate. Future improvements in ONT technology offer the 316 possibility of reducing the error rate to 2-3%, which in turn should improve Clair's ability to 317 detect indels in these data. 318
319
The GIAB datasets we used for model training have moderate whole-genome sequencing 320 coverage. Although we can use samples with very high coverage (over 300-fold, which is 321 sometimes seen in amplicon sequenced data) with Clair for variant calling, such samples 322 might show degraded performance because very high coverage variants were not 323 adequately observed in model training. To solve this problem, we propose two methods. 324
One method is to do transfer learning using a trained model on additional datasets with 325 very high coverage. Clair supports transfer learning and can be applied to additional 326 datasets instantly. Another method is an ensemble method, which generates multiple 327 copies of randomly subsampled read alignments at a candidate variant for Clair to call 328 variant. A majority vote or a decision tree can be used to make the final decision, using the 329 results of each copy. alternative alleles, which could not be called in Clairvoyante. The zygosity task outputs the 364 probability of the input being 1) a homozygous reference (0/0); 2) heterozygous with 1 or 2 365 alternative alleles (0/1 or 1/2); or 3) a homozygous variant (1/1). The zygosity task is 366 partially redundant to the 21-genotype task, but it makes decisions independently, and it 367 crosschecks the decision made by the 21-genotype task. Tasks three and four have the same 368 design. They output the length of up to two indel alleles. Each task outputs 33 probabilities, 369
including the likelihood of 1) more than 15bp deleted (<-15bp); 2) any number between -370 15bp and 15bp, including 0bp, and; 3) more than 15bp inserted (>15bp). In training, the 371 indel allele with a smaller number is set as the first indel allele. For example, for a 372 heterozygous 1bp deletion, the first indel allele is set as -1bp, the second as 0bp (-1bp/0bp). 373 genotype concluded by Clair, we choose 1) the insertion/deletion with the highest allelic 397 count for 'AI', 'CI', 'GI', 'TI', 'AD', 'CD', 'GD' and 'TD'; 2) the insertions with the highest and/or 398 the second-highest allelic count for 'II'; 3) the deletions with highest and/or the second-399 highest allelic count for 'DD', or; 4) both the insertion and deletion with the highest allelic 400 count for 'ID'. The additional step is slow, but it is required only for indels longer than 15bp. 401
We investigated HG001 and found 570,367 indels in its truth variant set; only 10,672 402
(1.87%) were >15bp. In our experiments, we found the slowdown was acceptable. Users can 403 set an option in Clair to enable this additional step for all indels, but our experiments found 404 that while the improvement in precision is small, it slows down Clair by about two times 405 with Illumina and PacBio CCS data, and by more than 10 times on ONT data. 406
407
Determining the most probable variant type using the four Clair tasks 408
Clair outputs data on four tasks. With an independent penultimate layer (Figure 1, FC5  409 layer) immediately before each task, the output of each task is considered independent. We 410 made two observations from our experiments: 1) for true positive variants, a random task 411 or two will make a mistake occasionally, but usually, the best and the second-best 412 probabilities are near and can be disambiguated if considered with other tasks; 2) for false 413 positive variants, the tasks do not usually agree well with each other, leading to two or 414 more possible decisions with similar probabilities. Thus, in Clair, we implemented a method 415 as a submodule for making a decision using the output of all four tasks. Variants are divided 416 into 10 categories: 1) a homozygous reference allele; 2) a homozygous 1 SNP allele; 3) a 417 heterozygous 1 SNP allele, or heterozygous 2 SNP alleles; 4) a homozygous 1 insertion allele; 418 5) a heterozygous 1 insertion allele, or heterozygous 1 SNP and 1 insertion alleles; 6) 419 heterozygous 2 insertion alleles; 7) a homozygous 1 deletion allele; 8) a heterozygous 1 420 deletion allele, or heterozygous 1 SNP and 1 deletion alleles; 9) heterozygous 2 deletion 421 alleles; and 10) a heterozygous 1 insertion and 1 deletion alleles. The likelihood value of the 422 10 categories is calculated for each candidate variant, and the category with the largest 423 likelihood value is chosen (Pseudocode in "Supplementary Note -Pseudo code for 424 determining the most probable variant type"). The variant quality is calculated as the square 425 of the Phred score of the distance between the largest and the second-largest likelihood 426 values. 427
428 Cyclical learning rate 429
The "initial learning rate" and "how the learning rate decays" are two critical 430 hyperparameters in training a deep neural network model. A model might be stuck at a local 431 optimum (i.e. unable to achieve the best precision and recall) if the initial learning rate is 432 too large, or the decay is too fast. But a large initial learning rate, and a slow decay rate 433 make the training process either unstable or take too long to finish. So in common practice, 434 a tediously long grid search that is very costly is needed to find the best hyperparameters. 435 Furthermore, through a grid search, we found that different sequencing technologies differ 436 in their best hyperparameters. This problem makes model training too complicated and 437 largely impedes Clair from being applied to new datasets and sequencing technologies. To 438 solve the problem, we implemented Cyclical Learning Rate (CLR) 22 in Clair. CLR is a new deep 439 learning technique that eliminates the need to find the best values of the two 440 hyperparameters. CLR gives a way to schedule the learning rate in an efficient way during 441 training, by cyclically varying between a lower and higher threshold. Following the CLR 442 paper, we determined the higher threshold to be 0.03 and the lower threshold to be 0.0001. 443
The two thresholds worked well on the training variants of all three sequencing 444 technologies (Illumina, PacBio CCS and ONT). In terms of which CLR scheduler to use, we 445 chose the triangular schedule with exponential decay. In our experiments, on PacBio CCS 446 and Illumina datasets, CLR decreased model training time by about 1-3 times, while often 447 outperforming the three-step decay method introduced in Clairvoyante for both precision 448 and recall. However, on ONT datasets, CLR has a lower, but almost negligible, performance 449 than the three-step decay. We provide both CLR and three-step decay options in Clair. To 450 train a model for production, we suggest users try both options and choose the best 451 through benchmarking. In our results, we used CLR for PacBio CCS and Illumina datasets, 452 and the three-step decay method for ONT datasets. In this section we discuss methods we tested that had no effect on Clair's performance. For 491 researchers working on further improving the performance of Clair, these methods could be 492 avoided or revised. 493
Extend input tensor from 33bp to 49bp and 65bp 495
Intuitively, a larger input tensor with more flanking bases provides additional information 496 on the surrounding read alignments, which might lead to better precision and recall. Our 497 experiments show that extending the input tensor from 33bp (16bp flanking bases) to 49bp 498 (24bp flanking bases) and 65bp (32bp flanking bases) slows down Clair by 5.4% and 12.6%, 499 respectively. But the improvement was negligible in terms of precision or recall with both 500 SNP and indel. 501
502
Using non-variants adjacent to true variants as negative samples for model training 503
Clair, by default, uses a ratio of 1:2 on true variants and non-variants for model training, and 504 the non-variants are randomly selected from the genome, except for the positions with a 505 true variant or insufficient coverage. We experimented using non-variants adjacent to true 506 variants (we tried ±2bp, ±8bp and ±16bp) as negative samples for model training and 507 adjusted the ratio to 1:1:1 on true variants adjacent non-variants and random non-variants. 508
We used adjacent non-variants for training because their input is true variant alike, but a 509 few bases shifted. The hypothesis was that using them as adversarial training samples 510 to the truth variants and high-confidence regions are available in "Methods -Data sources -546
Truth variants". Depending on the reference genome used in the already available read 547 alignments, we used GRCh38 for our ONT and Illumina experiments, and GRCh37 for our 548
PacBio CCS experiments. The links to the reference genomes we used are available in 549 "Methods -Data sources -Reference genomes" 550 551 Removing GA4GH low-complexity regions from benchmarking 552 Krusche et al. 6 from the GA4GH benchmarking team and the GIAB consortium published the 553 low-complexity regions, including homopolymers, STRs, VNTRs, and other repetitive 554 sequences for stratifying variants in their paper titled "Best practices for benchmarking 555 germline small-variant calls in human genomes". In the low-complexity regions larger than 556 10bp, ONT's performance degraded significantly (precision -11.41%, recall -55.33%), while 557 that of PacBio CCS and Illumina dropped only 0.99-1.67% in precision and recall 558 ( Supplementary Table 5 ). Thus, when computing variant calling using ONT, we suggest 559 removing the variants called in the low-complexity regions. In our benchmarks for all 560 datasets, in addition to using the high-confidence regions of each sample provided by GIAB, 561 we removed the low-complexity regions. The procedures are available in "Supplementary 562
Note -Commands -Remove GA4GH low complexity regions from GIAB's high-confidence 563 regions". There was retention of 92.61-93.47% high-confidence regions in GRCh38, and 564 94.40-95.05% in GRCh37 of the five samples HG001 to 5 after removing the low-complexity 565 regions ( Supplementary Table 8 ). 566
567
Benchmarking methods and metrics 568 Clair trains a model either for 30 epochs, using the Cyclical Learning Rate (used for PacBio 569 CCS and Illumina datasets), or by decaying the learning rate three times (by one tenth each 570 time) until the validation losses converge (used for ONT datasets). While the performance of 571 last few epochs are generally similar, the best-performing one will be chosen for 572 benchmarking. We did not run replications of model training because choosing from the 573 best epoch actually resembles the process of having multiple replications. In ONT and 574
Illumina experiments, the GRCh38 reference genome was used, while in PacBio CCS 575 experiments, GRCh37 was used. For each variant calling experiment, we used the 576 submodule vcfeval in RTG Tools 24 version 3.9 to generate three metrics, 'Precision', 'Recall', 577 and 'F1-score', for five categories of variants: 'Overall', 'SNP', 'Indel', 'Insertion', and 578 'Deletion'. All time consumptions were gauged on two 12-core Intel Xeon Silver 4116 (in 579 total 24 cores), with 12 concurrent Clair processes, each with 4 Tensorflow threads. As Clair 580 has some serial steps that use only one thread, we observed our setting sufficient to 581 maximize the utilization of all 24 cores. For other variant callers, including DeepVariant, 582
Longshot and Medaka, options were to set to use all 24 cores for the best speed. 
